NCT03034304 2025-07-24A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid TumorsHRYZ Biotech Co.Phase 1 Terminated105 enrolled
NCT04189952 2025-05-31Acalabrutinib in Combination With R-ICE For Relapsed or Refractory LymphomaUniversity of MiamiPhase 2 Terminated2 enrolled 6 charts